[Clinical test on the effect of the new antihistaminic preparation HS-592 (Tavegyl, Sandoz)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000188:drug therapy; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014581:Urticaria / Q000188:drug therapy
D006634:Histamine H1 Antagonists
Doświadczenia kliniczne nad dzialaniem nowego preparatu przeciwhistaminowego Hs-592 (Tavegyl) firmy Sandoz.